PRESS RELEASE - Breast Cancer: Counterfeit Synthetic Hormones vs. Bio-identical Hormones
FOR IMMEDIATE RELEASE
Hotze Health & Wellness Center Contact: Steven F. Hotze, M.D.
20214 Braidwood, Houston, Texas 77450 281.698.8698
Today’s Date – December 16, 2008
Breast Cancer: Counterfeit Synthetic Hormones vs. Bio-identical Hormones
The Associated Press distributed an article for publication in newspapers across the country on December 13, 2008 entitled, “New Study firmly ties hormone use to breast cancer”. The title of this article erroneously refers to “hormone use”, when it should correctly be entitled “counterfeit hormone and synthetic drug” use. It discusses the results of the Women’s Health Initiative (WHI), a study which was launched in 1991 and involved 161,808 postmenopausal women. The clinical trials were designed to test the effects of postmenopausal hormone therapy, diet modification, and calcium and vitamin D supplements on heart disease, fractures, as well as breast and colorectal cancer. This initiative had two studies: the synthetic estrogen-plus-progestin study of women with a uterus and the synthetic estrogen-alone study of women without a uterus. It did not study the effects of bio-identical human hormones.
This article correctly states that Prempro increases the risk of breast cancer in women who use it. This is what our Center expected since Prempro is not a hormone which naturally occurs in women. It is a combination of horse estrogens extracted from pregnant mare’s urine and a counterfeit, synthesized progestin. The progestin, medroxyprogesterone, is not a naturally occurring molecule and is a drug which is foreign to the human body. Wyeth, the manufacturer of both Prempro and Premarin, admits to not knowing all the types of horse estrogen contained in Premarin.
What is not mentioned in this article is the fact that breast cancer is commonly caused by hormonal imbalance. While the three female estrogen hormones, estrone, estradiol and estriol are essential hormones, the risk of breast cancer is directly related to either an excess of estrogen or an imbalance between the estrogen hormones and progesterone. A number of studies have found that a progesterone deficiency may play an important role in increasing a woman’s risk of breast cancer.
Progesterone and estrogen operate in balance and the optimal balance of these two hormones is crucial to a woman’s health and well being. Correcting this imbalance, which is called estrogen dominance and increases as women progress through their menstrual lives, is key to decreasing the risk of breast cancer. Bio-identical progesterone helps to reduce the risk of breast cancer by balancing the estrogen in your body.
This was the conclusion of the Johns Hopkins University’s School of Public Health study, published in the August 1981 edition of the American Journal of Epidemiology. This study demonstrated that women who were infertile due to a progesterone deficiency had a premenopausal breast cancer risk that was 540% greater than those women whose infertility was not related to a progesterone deficiency. This study also found that women with progesterone deficiency had a 1,000 % greater risk of death from all types of cancer.
The Food and Drug Administration (FDA) should prohibit counterfeit hormones, such as Premarin and Prempro from being marketed and prescribed.
Natural, bio-identical hormones provide a safe, natural alternative for women who are experiencing significant side effects from hormonal decline and imbalance.
•
del.icio.us
digg
facebook
E-mail this article to a friend (requires login).
